经口机器人手术后术后出血与再就诊情况
基于佛罗里达、纽约和加州2005至2013年州住院、门诊手术及急诊数据库的回顾性分析,共纳入509例经口机器人手术患者,41例(8%)发生术后出血,中位时间9天,24例(5%)需干预,16例(3%)重返手术室止血,11例(2%)发生需栓塞或气管切开的严重并发症;Charlson合并症评分≥3分和扁桃体肿瘤与术后出血显著相关。
要点
- 经口机器人手术后出血发生率为8%,中位术后9天出现。
- 5%需干预,3%重返手术室止血,2%发生需栓塞或气管切开的严重并发症。
- Charlson合并症评分≥3分和扁桃体肿瘤是与术后出血显著相关的因素。
核心结论
- 经口机器人手术后术后出血发生率低,发生出血者中仅少数出现严重并发症。
- 医学合并症和扁桃体亚部位可能是术后出血的独立危险因素。
- 这些数据为经口机器人手术的知情决策提供基准,并为进一步研究奠定基础。
研究设计与样本
- 回顾性分析2005至2013年佛罗里达、纽约和加州州住院数据库、州门诊手术数据库及州急诊数据库。
- 共纳入509例接受经口机器人手术的患者。
- 手术指征包括肿瘤性疾病376例(74%)和睡眠呼吸暂停74例(15%)。
主要发现
- 41例(8%)发生术后出血,中位时间为术后9天(范围0至21天)。
- 24例(5%)需针对术后出血进行干预。
- 16例(3%)需重返手术室控制出血。
- 11例(2%)发生需栓塞或气管切开的严重并发症。
- Charlson合并症评分≥3分(OR=3.02,95%CI=1.45-6.30)和扁桃体肿瘤(OR=1.96,95%CI=1.03-3.74)与术后出血显著相关。
关键数值与推荐
- 术后出血定义为术后发生的出血事件,41例(8%)出现,中位时间9天。
- Charlson合并症评分≥3分与术后出血的OR=3.02(95%CI=1.45-6.30)。
- 扁桃体肿瘤与术后出血的OR=1.96(95%CI=1.03-3.74)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To investigate the incidence and complications related to postoperative hemorrhage (POH) after transoral robotic surgery (TORS). STUDY DESIGN: Retrospective review of the State Inpatient Database (SID), the State Ambulatory Surgery Database (SASD), and the State Emergency Department Database (SEDD) from the Healthcare Cost and Utilization Project. METHODS: Patients were identified from the SID, SASD, and SEDD for the states of Florida, New York, and California from 2005 to 2013 who had an International Classification of Diseases, Ninth Edition code for a surgical procedure on the upper aerodigestive tract associated with a code for robotic-assisted surgery. Univariate logistic regression was used to explore factors associated with POH. RESULTS: Five hundred nine patients underwent TORS. Indications for surgery included neoplastic disease in 376 (74%) and sleep apnea in 74 (15%). Forty-one (8%) had an episode of POH at a median of 9 days postoperatively (range = 0-21 days). Twenty-four (5%) required an intervention related to their POH. Sixteen (3%) required return to the operating room for control of hemorrhage; 11 (2%) had a severe complication that required embolization or tracheostomy. Charlson Comorbidity Score of ≥3 (odds ratio [OR] = 3.02, 95% confidence interval [CI] = 1.45-6.30) and a tonsillar neoplasm (OR = 1.96, 95% CI = 1.03-3.74) were significantly associated with POH. CONCLUSIONS: The incidence of POH after TORS was low, and few of these patients had a severe complication related to this event. Medical comorbidity and tonsillar subsite may be independent risk factors for POH. These data provide a benchmark for informed decision making in TORS and a basis for further study. LEVEL OF EVIDENCE: 4. Laryngoscope, 127:2287-2292, 2017.
引用
- Zenga J, Suko J, Kallogjeri D, et al. Postoperative hemorrhage and hospital revisit after transoral robotic surgery. Laryngoscope. 2017. PMID: 28425577. doi:10.1002/lary.26626
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。